Is There a Need or an Evidence for Rebiopsying Patients after a First TUR

EAU Update Series Pub Date : 2003-06-01 Epub Date: 2003-05-27 DOI:10.1016/S1570-9124(03)00017-5
T Otto , J Suhr , H Rübben
{"title":"Is There a Need or an Evidence for Rebiopsying Patients after a First TUR","authors":"T Otto ,&nbsp;J Suhr ,&nbsp;H Rübben","doi":"10.1016/S1570-9124(03)00017-5","DOIUrl":null,"url":null,"abstract":"<div><p>Quality of TUR performed by individual urologist is of great importance for the high variability in the residual tumor rate at first follow-up cystoscopy. Endoscopy done under fluorescence has a significantly improved sensitivity for detecting bladder tumors. Concerning database of the EORTC and registry of urinary tract tumors a re-TUR is mandatory in poorly differentiated T1 tumors and should be recommended in T1 G1–2 cancer as well as in patients with multiple Ta tumors where complete removal of papillary tumor is not possible.</p></div>","PeriodicalId":100385,"journal":{"name":"EAU Update Series","volume":"1 2","pages":"Pages 87-90"},"PeriodicalIF":0.0000,"publicationDate":"2003-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1570-9124(03)00017-5","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EAU Update Series","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1570912403000175","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2003/5/27 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Quality of TUR performed by individual urologist is of great importance for the high variability in the residual tumor rate at first follow-up cystoscopy. Endoscopy done under fluorescence has a significantly improved sensitivity for detecting bladder tumors. Concerning database of the EORTC and registry of urinary tract tumors a re-TUR is mandatory in poorly differentiated T1 tumors and should be recommended in T1 G1–2 cancer as well as in patients with multiple Ta tumors where complete removal of papillary tumor is not possible.

第一次TUR后是否需要或有证据对患者进行再活检
由于首次随访膀胱镜检查中残余肿瘤率的差异很大,泌尿科医师的TUR质量非常重要。荧光内镜对膀胱肿瘤的检测灵敏度有显著提高。在EORTC数据库和尿路肿瘤登记中,低分化T1肿瘤必须进行re-TUR,在T1 G1-2肿瘤以及无法完全切除乳头状肿瘤的多发Ta肿瘤患者中,应推荐进行re-TUR。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书